Umeå Biotech Incubator (UBI) is ending its program season with the "Life science super week" between May 8th-10th 2023 - an action-packed three-day event filled with seminars, an investment day, a life science pub plus a brand new services business fair.
G4 Cancer Cure, a biotech research initiative located in Umeå in northern Sweden, has attracted considerable interest from doctors and the pharmaceutical industry for a new treatment method it is developing for triple-negative breast cancer.
The Board of Directors of Umeå Biotech Incubator (UBI) has announced that CEO Jennie Ekbeck is leaving her post after eleven years.
Umeå-based pharmaceutical company Vakona has been given a capital injection of just over SEK 14 million from five investors to help it develop a new drug to treat acne.
Xerum became nationally known for its self sampling and one of the world's most sensitive antibody test during the Covid pandemic. Now the Umeå company has been nominated for the MedTech4Health Innovation Award.
Two cases in the pre-incubator break new ground at Umeå Biotech Incubator. Jonathan Love and Cropcision work in agtech and Daniel Pacurar is developing an idea in biotechture with his case Shades of Green.
Brian Reznik, CEO and co-founder of the Argentinian startup Nanotransfer, hails the International Incubator Program at Umeå Biotech Incubator. "The business coaches were very perceptive and understood our challenges and what we are trying to achieve," he says.
The life science industry in Umeå is well represented at the local business gala Umeågalan in March. Cytiva, Sartorius Stedim Data Analytics and Spinchem are nominated in four different categories.
In 2019 the research group behind R&D company Neores won both the Athena prize and the Medtech4Health Innovation Award for their rPAP breathing aid designed for babies born too early. Now Neores has announced it is taking the next step in building its business by joining Umeå Biotech Incubator (UBI).
The life science company InfiCure Bio has started the new year in the best way by signing an agreement with a new client in the US. "The company's goal for 2023 is to increase the visibility of our NIF model by continuing our strategy to promote the model on multiple markets”
Umeå Biotech Incubator (UBI) will represent Umeå’s life science industry as part of the annual ‘Västerbotten på Grand Hôtel i Stockholm’ event being held in January. “We want to contribute to Umeå’s growth as a life science city by connecting the life science industry with local, regional, and national decision-makers”, says UBI’s CEO Jennie Ekbeck.
Umeå-based life science company Diamyd Medical continues to recruit specialists for its new manufacturing unit.
“For a scientist it is a fun and challenging place to work, where you really feel your knowledge makes a big difference and means something”, says Maria Åhman, Quality Assurance Manager at Diamyd Medical.
The company announced it was moving the production of GAD65 protein, the acti